Deepak Nitrite's strong margins and new products drive upgraded FY27 earnings estimates

Investment View and Recommendation

In its August 6, 2026 1QFY27 result update, Motilal Oswal Financial Services retained its Sell recommendation on Deepak Nitrite with a target price of Rs 1,500, versus a CMP of Rs 1,750. The broker said the company delivered resilient operating performance despite industry headwinds, but near-term performance may remain affected by pricing volatility, geopolitical developments and an uneven demand recovery.

Motilal Oswal expects the impact of these factors to be contained by process improvements, backward integration, manufacturing efficiencies, disciplined cost optimisation, improving customer enquiries and new-product commercialisation.

1QFY27 Financial Performance

Deepak Nitrite reported 1QFY27 revenue of Rs 25.8 billion, up 36% year on year and above Motilal Oswal's estimate of Rs 21.5 billion. Growth was led by a 36% increase in Phenolics revenue to Rs 17.7 billion and a 33% increase in Advanced Intermediates revenue to Rs 8.0 billion.

Phenolics EBIT increased 3.5 times year on year, while Advanced Intermediates EBIT grew 89%. Segment EBIT margins were 23.5% for Phenolics and 8.3% for Advanced Intermediates.

Management attributed the performance to the integrated operating model, healthy utilisation, a favourable product mix, recent integration initiatives, better phenol and benzene spreads, and cost discipline. Domestic revenue represented 85% of the mix, while exports accounted for 15%.

Business Performance and Growth Drivers

Advanced Intermediates

Stabilisation of the nitration and hydrogenation facilities has improved manufacturing flexibility and raw-material security. Management expects debottlenecking, nitric acid, nitration- and hydrogenation-based products, specialty agrochemicals and multipurpose plants to support growth.

New products remain under customer qualification. Management expects their margins to be in line with or above the segment average.

Phenolics

The Phenolics business delivered a record quarter, supported by favourable spreads, strong domestic realisations, stable demand, strategic benzene sourcing and process optimisation. Management said the global phenol market is balanced, with limited capacity additions, while India remains structurally supply-deficit.

Motilal Oswal believes Deepak Nitrite's integrated phenolics chain and the reimposition of import duty on phenol should support competitiveness and profitability.

Projects, Integration and Capital Expenditure

The Multipurpose Agrochemical Intermediate Facility and the MIBK, MIBC and Acetophenone projects are expected to be commissioned in 2QFY27. MIBK and MIBC quality has been approved by clients. These projects are intended to deepen downstream integration, broaden the product basket and support medium-term margin accretion.

The polycarbonate project remains targeted for commissioning in 2HFY28. Equipment relocation from Germany, civil work and procurement are progressing. A long-term HyCO supply agreement has been secured, and early customer qualification is under way.

The company plans around Rs 32 billion of capital expenditure, primarily for backward integration and value-added products. Renewable-energy investments generated around Rs 45 million of savings in 1QFY27.

Earnings Estimates and Valuation

Following the margin outperformance, Motilal Oswal increased its FY27E and FY28E estimates as follows:

The broker forecasts FY26–28 revenue, EBITDA and PAT CAGRs of 13%, 22% and 24%, respectively. The target price of Rs 1,500 is based on 24 times FY28E EPS.

Key Risks and Near-Term Considerations

• Pricing volatility, geopolitical developments and an uneven demand recovery may affect near-term performance.
• The outlook remains dependent on the successful commercialisation of new products and customer qualifications.
• The expected benefits from debottlenecking, integration initiatives and new projects will depend on timely commissioning and operational execution.